Welcome to Euronext's educational guide on bonds and bond markets, tailored specifically for retail investors seeking to expand their understanding of this vital segment of the financial landscape.

Cloudberry Clean Energy ASA ("Cloudberry" or the "Company) has entered into an agreement with a European infrastructure investor ("the Investor") to establish one of the largest small-scale hydro ...

Home Equities - Stocks - Shares Company Press Releases 2020 Bulkers Ltd. (2020) Commercial Update and Key Information Relating To The Dividend For June 2025 ...

8 July 2025 - ReFuels N.V., a leading European supplier of renewable biomethane (Bio-CNG) for the decarbonisation of heavy goods vehicles (HGVs), today published Bio-CNG station data for June 2025. * ...

Cloudberry Clean Energy ASA ("Cloudberry" or the "Company"), together with Hafslund Vekst AS, is pleased to announce that the partners have reached a final investment decision (FID) in the joint ...

is owned by HC (60%) and HSC (40%). The condition for completion of the Offer relating to "Minimum Acceptance" as set out in section 1.3 of the Offer Document has, as previously announced, already ...

Press ReleaseVELIZY-VILLACOUBLAY, France — July 7, 2025 Half-year statement of the Liquidity contract entered into with Oddo BHF SCA Das ...

(July 9, 2025 - Oslo, Norway) Nel ASA (Nel, OSE:NEL) will publish its second quarter 2025 report on 16 July 2025 at 07:00 CET, and host a pr ...

Home Equities - Stocks - Shares Company Press Releases Ensurge Micropower ASA - Business Update and Contemplated Fully Underwritten Private Placement ...

Fornebu, Norway – 8 July 2025 – Telenor announces the acquisition of GlobalConnect’s consumer business in Norway in a transaction valued at NOK 6.0 billion. The deal marks a significant strategic step ...

Reference is made to stock exchange notice of 1 March 2024, where Endúr ASA (“The Company”) announced its plan to buy up to 1,629,741 own shares for a total maximum NOK 50 million. In week 27 2025, ...

Oslo, Norway, July 9, 2025 – Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that a ...